Looking like something about to start here!
Orbit Stocks and Mega Penny Stock Pick promoting AMBS tonight.
THIS: "We are issuing an alert on AMBS tonight because we are hearing rumors of some big things coming her way!
AMBS chart is set to blast off here, and any catalyst will make her shoot up.
AMBS is one of those bio-tech plays that may very well make it to the big leagues...and we all know what that means!...."
AND THIS:
"Amarantus BioScience Holdings, Inc. (AMBS) is a development-stage, publicly-traded biotechnology company discovering & developing first-in-class treatments for diseases associated with the dysfunction of a wide range of biological pathways, beginning with apoptosis.
Neurodegenerative diseases such as Parkinson’s, ALS and Alzheimer’s as well as Cardiovascular Disease such as Myocardial Infarction, Angina, Coronary Artery Disease and Heart Failure are in need of treatments that address the region specific apoptosis associated with each disorder. The Company has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinson’s Disease and other human diseases.
Amarantus owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. Amarantus is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and TBI. The Company also has a diagnostic program led by NuroPro® which is aimed at developing diagnostic blood tests that are capable of early identification of apoptosis-related medical conditions while tracking their progression over time.
Amarantus’ Management Team and Board of Advisors have designed a business strategy to formulate and advance pre-clinical and clinical programs for the Company's product candidates through successive de-risking milestones in order to maximize their commercial potential. The Company is also focused on making the assets attractive partnering targets for product development focused biotechnology, pharmaceutical, medical device and diagnostic companies.
Amarantus BioScience Holdings, Inc.(AMBS) intends to advance its therapies and diagnostics to provide patients with safe and effective treatment options in the care of their chronic illnesses
For More information about AMBS, Visit the company's website www.amarantus.com
Happy Trading"
